Uzbekistan bans 2 Indian cough syrups after they were found "substandard"
New Delhi : The World Health Organization (WHO) has banned 2 Indian cough syrups made by Noida-based company Marion Biotech as they were found substandard for use on children.
In a medical product alert on Wednesday, the WHO claimed "substandard medical products", manufactured by Marine Biotech, as they failed to meet quality standard or specifications.
"This WHO Medical Product Alert refers to two substandard (contaminated) products, identified in Uzbekistan and reported to WHO on 22 December 2022. Substandard medical products are products that fail to meet quality standards or specifications and are therefore out of specification," the WHO said in an alert released on its website.
"The two products are AMBRONOL syrup and DOK-1 Max syrup. The stated manufacturer of both products is MARION BIOTECH PVT. LTD, (Uttar Pradesh, India). To date, the stated manufacturer has not provided guarantees to WHO on the safety and quality of these products," the alert added.
The alert has been sounded after reports of deaths in children in Uzbekistan who consumed the syrups.
According to the report by WHO, both the products contain unacceptable amount of diethylene glycol or ethylene glycol as contaminants.
On December 22, Uzbekistan alleged that around 18 children lost their lives after they consumed medicines manufactured by Marion Biotech Company. Meanwhile, in Uttar Pradesh, the Food Safety and Drug Administration Department has suspended the production license of marine Biotech company linked to Uzbekistan's deaths.
India is also not testing the samples of the curious manufactured by this company. The reports are awaited.
